Twice each month the CEA Registry Blog lists recently published cost utility studies and associated papers. 50 papers were listed this time. Here's a few in our areas of research interest:
Ström O, Jönsson B, Kanis JA. Intervention thresholds for denosumab in the UK using a FRAX(®)-based cost-effectiveness analysis. Osteoporos Int. 2012 Dec 7. [Epub ahead of print] PubMed PMID: 23224141.
Behl AS, Goddard KA, Flottemesch TJ, et al. Cost-Effectiveness Analysis of Screening for KRAS and BRAF Mutations in Metastatic Colorectal Cancer. J Natl Cancer Inst. 2012 Dec 5;104(23):1785-95. Epub 2012 Nov 28. PubMed PMID: 23197490; PubMed Central PMCID: PMC3514165.
Beale SJ, Bending MW, Trueman P, et al. Should we invest in environmental interventions to encourage physical activity in England? An economic appraisal. Eur J Public Health. 2012 Dec;22(6):869-73. Epub 2012 Feb 24. PubMed PMID: 23132876.
Hettle R, Wouters H, Ayres J, et al. Cost-utility analysis of tiotropium versus usual care in patients with COPD in the UK and Belgium. Respir Med. 2012 Dec;106(12):1722-33. Epub 2012 Oct 3. PubMed PMID: 23040833.